Business Context and Reporting Period
This Form 8-K reports the results of the 2023 Annual Meeting of Stockholders for Protagonist Therapeutics, Inc., held on May 25, 2023. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market under the symbol PTGX.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Stockholders voted on three proposals at the Annual Meeting. All proposals were approved or the nominee was elected as follows:
- Proposal 1 (Election of Director): Dr. Dinesh V. Patel was elected as a Class I director. Votes cast were 32,660,198 For, 8,874,076 Withheld, and 3,298,693 Broker Non-Votes.
- Proposal 2 (Executive Compensation): The advisory vote to approve named executive officer compensation was approved. Votes cast were 39,838,516 For, 1,673,050 Against, 22,708 Abstentions, and 3,298,693 Broker Non-Votes.
- Proposal 3 (Ratification of Auditors): The selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified. Votes cast were 44,807,871 For, 15,794 Against, and 9,302 Abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves solely to disclose the voting results of the Annual Meeting.
Investor Verification Checklist
- Verify the tenure of the newly elected director, Dr. Dinesh V. Patel, which extends until the 2026 Annual Meeting.
- Confirm the level of shareholder support for executive compensation, noting approximately 96% of votes cast were in favor.
- Review the definitive proxy statement filed on April 12, 2023, for detailed descriptions of the proposals and director biographies.
- Check subsequent filings for the company's financial performance, as this 8-K contains no financial data.